Evidence map›Paper›PMID 37211959›Full record

ArticleCancer2023

Tobacco use and cancer-related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study.

Sarah N Price, Amanda M Palmer, Lisa M Fucito, Evan M Graboyes, Nathaniel L Baker, Alana M Rojewski, Benjamin A Toll

Abstract read
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network Trials.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah N PriceDepartment of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0002-1622-1700
Amanda M PalmerDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-5833-034X
Lisa M FucitoDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Evan M GraboyesDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0003-3766-468X
Nathaniel L BakerDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Alana M RojewskiDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0003-1531-9287
Benjamin A TollDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J Lemasters · 2009 to 2026
$42.7M
Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY · 2018 to 2026
$41.6M
Pulmonary Focused Foundations in Innovation and Scholarship (PuFFInS)T32HL144470 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Carol A. Feghali-Bostwick · 2019 to 2026
$2.6M
Cancer Prevention And Control Training Grant (CAPACITY)T32CA122061 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRISTIE L FOLEY, Kathryn Elizabeth Weaver · 2019 to 2026
$2.1M
Scleroderma Twin Study and analysis of Estrogen in patients with dcSScK24AR060297 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FEGHALI-BOSTWICK, CAROL A. · 2013 to 2025
$1.4M
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA138313NCI NIH HHS T32 CA122061NHLBI NIH HHS T32 HL144470NIAMS NIH HHS K24 AR060297NIDA NIH HHS U54 DA036151NIH HHS NIH-T32-HL144470NIH HHS P30 CA 138313NIH HHS T32CA122061
6 · The paper itself

Abstract

backgroundUnderstanding the relationship between tobacco use and symptom burden may inform tobacco treatment interventions tailored to the needs of individuals with cancer.

methodsThe study included 1409 adult cancer survivors from Wave 5 of the US Food and Drug Administration Population Assessment of Tobacco and Health (PATH) Study. A multivariate analysis of variance controlling for age, sex, and race/ethnicity assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life (QoL). Generalized linear mixed models controlling for the same factors were used to assess associations among symptom burden, QoL, and quit-smoking intentions, quit-smoking likelihood, and past 12-month smoking quit attempts.

resultsWeighted rates of current cigarette smoking and vaping were 14.21% and 2.88%, respectively. Current smoking was associated with greater fatigue (p < .0001; partial η

conclusionsAmong adults with cancer, current smoking and vaping were associated with greater symptom burden. Survivors' interest in and intentions to quit smoking were not related to symptom burden. Future research should examine the role of tobacco cessation in improving symptom burden and QoL.

Indexed as

Cigarette SmokingElectronic Nicotine Delivery SystemsNeoplasmsSmoking CessationTobacco ProductsVapingAdultFatigueHumansPainQuality of Lifecancer survivorsemotional distressfatiguepainquality of lifetobacco usevaping

Identifiers

PMID37211959
PMCPMC10593116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.